Literature DB >> 34800721

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.

Pegah Golabi1, James M Paik1, Katherine Eberly2, Leyla de Avila1, Saleh A Alqahtani3, Zobair M Younossi4.   

Abstract

INTRODUCTION AND
OBJECTIVES: Cause of mortality in patients with chronic liver diseases (CLDs) may differ based on underlying etiology of liver disease. Our aim was to assess different causes of death in patients with the most common types of CLD using a national database from the United States.
MATERIALS AND METHODS: Death data from 2008 and 2018 from the National Vital Statistics System (NVSS) by the National Center for Health Statistics (NCHS) were used. The rank of cause-of-death for each etiology of CLDs was assessed. Causes of death were classified by the ICD-10 codes. Liver-related deaths included liver cancer, cirrhosis and CLDs.
RESULTS: Among a total of 2,826,531 deaths in 2018, there were 85,807 (3.04%) with underlying CLD (mean age at death 63.0 years, 63.8% male, 70.8% white). Liver-related mortality was the leading cause of death for all types of CLD [45.8% in non-alcoholic fatty liver disease (NAFLD), 53.0% in chronic hepatitis C (CHC), 57.8% in chronic hepatitis B (CHB), 81.8% in alcoholic liver disease (ALD)]. This was followed by death from cardiac causes (NAFLD 10.3%, CHC 9.1%, CHB 4.6%, ALD 4.2%) and extrahepatic cancer (NAFLD 7.0%, CHC 11.9%, CHB 14.9%, ALD 2.1%). Although liver cancer was the leading cause of cancer death, lung, colorectal and pancreatic cancer were also common causes of cancer death.
CONCLUSIONS: Among deceased patients with CLD, underlying liver disease was the leading cause of death. Among solid cancers, liver cancer was the leading cause of cancer-related mortality.
Copyright © 2021 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Alcoholic liver disease; Chronic hepatitis B; Chronic hepatitis C; Cirrhosis; Non-alcoholic fatty liver disease; Outcome; Trend

Mesh:

Year:  2021        PMID: 34800721     DOI: 10.1016/j.aohep.2021.100556

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  2 in total

Review 1.  Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.

Authors:  Gashaw Hassen; Abhishek Singh; Gizeshwork Belete; Nidhi Jain; Ivonne De la Hoz; Genesis P Camacho-Leon; Nitsuh K Dargie; Keila G Carrera; Tadesse Alemu; Sharan Jhaveri; Nebiyou Solomon
Journal:  Cureus       Date:  2022-05-30

2.  A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B.

Authors:  Yandong Chen; Qiang Liu; Jing Han; Siyu Gao; Qian Xiao; Xiaoli Huang; Lu Lu; Xiaolin Zhou
Journal:  Emerg Med Int       Date:  2022-10-03       Impact factor: 1.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.